Search Results - Redondo-Mueller, Mauricio

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Abstract 1587: Generation and characterization of novel bispecific molecules combining single-chain-CD40L with anti-CEA, anti-CD95L or anti-PD-L1 targeting moieties

    Abstract 1587: Generation and characterization of novel bispecific molecules combining single-chain-CD40L with anti-CEA, anti-CD95L or anti-PD-L1 targeting moieties by Schroeder, Matthias, Billian-Frey, Katharina, Sykora, Jaromir, Redondo-Mueller, Mauricio, Heinonen, Karl, Frankish, Jamie, Gieffers, Christian, Thiemann, Meinolf, Hill, Oliver

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    The CD40 agonist HERA-CD40L results in enhanced activation of antigen presenting cells, promoting an anti-tumor effect alone and in combination with radiotherapy

    The CD40 agonist HERA-CD40L results in enhanced activation of antigen presenting cells, promoting an anti-tumor effect alone and in combination with radiotherapy by Frankish, Jamie, Mukherjee, Debayan, Romano, Erminia, Billian-Frey, Katharina, Schröder, Matthias, Heinonen, Karl, Merz, Christian, Redondo Müller, Mauricio, Gieffers, Christian, Hill, Oliver, Thiemann, Meinolf, Honeychurch, Jamie, Illidge, Tim, Sykora, Jaromir

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Preclinical Development of U3-1784, a Novel FGFR4 Antibody Against Cancer, and Avoidance of Its On-target Toxicity

    Preclinical Development of U3-1784, a Novel FGFR4 Antibody Against Cancer, and Avoidance of Its On-target Toxicity by Bartz, René, Fukuchi, Keisuke, Ohtsuka, Toshiaki, Lange, Tanja, Gruner, Katrin, Watanabe, Ichiro, Hayashi, Shinko, Oda, Yoko, Kawaida, Reimi, Komori, Hironobu, Kashimoto, Yoshinori, Wirtz, Peter, Mayer, Jan-Peter A, Redondo-Müller, Mauricio, Saito, Shuntaro, Takahashi, Mizuki, Hanzawa, Hiroyuki, Imai, Emi, Martinez, Alberto, Hanai, Masaharu, Häussinger, Dieter, Chapman, Roger W, Agatsuma, Toshinori, Bange, Johannes, Abraham, Reimar

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Abstract 3754: The novel hexavalent human CD137/4-1BB agonist HERA-CD137L promotes anti-cancer immunity by activating CD8 T cells while regulatory T cells are not affected

    Abstract 3754: The novel hexavalent human CD137/4-1BB agonist HERA-CD137L promotes anti-cancer immunity by activating CD8 T cells while regulatory T cells are not affected by Thiemann, Meinolf, Sykora, Jaromir, Richards, David M., Merz, Christian, Marschall, Viola, Mueller, Mauricio Redondo, Sefrin, Julian P., Heinonen, Karl, Fricke, Harald, Gieffers, Christian, Hill, Oliver

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Abstract 4963: Novel hexavalent GITR agonists stimulate T cells and enhance memory formation

    Abstract 4963: Novel hexavalent GITR agonists stimulate T cells and enhance memory formation by Thiemann, Meinolf, Gieffers, Christian, Richards, David M., Merz, Christian, Heinonen, Karl, Mueller, Mauricio Redondo, Marschall, Viola, Sykora, Jaromir, Fricke, Harald, Hill, Oliver

    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    HERA-GITRL activates T cells and promotes anti-tumor efficacy independent of FcγR-binding functionality

    HERA-GITRL activates T cells and promotes anti-tumor efficacy independent of FcγR-binding functionality by Richards, David M, Marschall, Viola, Billian-Frey, Katharina, Heinonen, Karl, Merz, Christian, Redondo Müller, Mauricio, Sefrin, Julian P, Schröder, Matthias, Sykora, Jaromir, Fricke, Harald, Hill, Oliver, Gieffers, Christian, Thiemann, Meinolf

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: